Policy on description of drug's manufacturing arouses concern in wholesaling industry

The government plans to make a thorough inspection on the description of manufacturing and lot numbers of drugs in the on-spot process of KGSP (Korea Good Supply Practice) ex post facto management to be implemented within this month but the domestic wholesaling industry opposes the plan on the grounds that such description is ineffective and if this is the case, their daily business is apt to b...